RVAC Medicines to Present at Vaccine Summit Boston 2022


RVAC Medicines will present one of its COVID-19 vaccine portfolio programs at the Vaccine Summit Boston 2022, highlighting the rapid advancement since its inception nine months ago. Dr. Jason Zhang, Chief Scientific Officer at RVAC Medicines, will share with the scientific community the preclinical data of RVAC’s variant SARS-CoV-2 mRNA vaccine as a single agent or booster, that induces neutralizing antibody responses and protects against viral challenge in studies using wild type, hACE2 Transgenic mice, and NHPs. Current COVID-19 vaccine portfolio at RVAC Medicines includes mRNA vaccines against Ancestor, Beta, Delta, Omicron BA1, and Omicron BA2 strains.

The presentation is scheduled on March 28, 2022, at 4:15 PM ET.

For more information, please visit  http://www.biogatesc.com/events/va-cc-in-e/

Copyright RVAC Medicines All rights reserved 2023

Terms of use